Black Rock Inc. Abbott Laboratories Call Options Transaction History

Black Rock Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $27.8 Million - $32.6 Million	-292,100 Reduced 26.8%	797,700 $87.6 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $73.9 Million - $85.6 Million	764,200 Added 234.71%	1,089,800 $105 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $33.2 Million - $40.2 Million	325,600 New	325,600 $35.4 Million

3,184

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.